ABSTRACT
There has been a consistent rise in opportunistic fungal infections (OFIs) over the previous two decades [1]. These are mainly due to impairments in host defense mechanisms as a consequence of viral infections (especially the human immunodeciency virus), premature neonates, age, major surgery, hematological disorders such as different types of leukemia, organ transplants, and more intensive and aggressive medical practices. Many clinical procedures and treatments, such as surgery, use of catheters, injections, radiation, chemotherapy, antibiotics, and steroids, are risk factors for fungal infections [2-7]. These types of infections are commonly known as mycoses. Nevertheless, there have been incidences of unusual OFI from different fungi that were previously presumed to be plant pathogens [8-13]. Thus, indications suggest that the epidemiological features of fungal infections are changing and that this group is becoming serious.
